Insider trade

Officer sold ~$269K of WST shares in the open market

Traded Apr 27, 2026 · Filed Apr 29, 2026

~$269K
Reported value · 896 sh @ $300.6688: 1,522.81
Holds after · shares reported: +20.8%
stock since the trade · S&P 500 +6.8%, $302.20 → $365.01 on Oct 1

Why it stands out

West Pharmaceutical Services's VP, Chief Accounting Officer sold $269K of West Pharmaceutical Services shares. Nobody planned it ahead of time.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Dates, kept separate

Transaction date: Apr 27, 2026
Reporting period: Not applicable
Filed with the SEC: Apr 29, 2026

Officer$100K–$500K

Context

Classification

open market sale

Code S — open-market or private sale

Absolute commitment

~$269,399

Shares × reported transaction price

Timing vs results

4 days after results of Apr 23, 2026, 87 days before results of Jul 23, 2026

Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results

Price at the time

Closed at $302.20 on Apr 27, 2026, within 3% of its 52-week high, after a 28% rise over the previous 30 trading days

52-week range $205.36 (May 6, 2025) to $309.70 (Apr 23, 2026), 93% of the way up, from 251 adjusted closes. 30 trading days earlier: $235.46 on Mar 13, 2026. Describes the past only, not a forecast

Planned / mechanical clue

None found in footnotes

Only flagged when a footnote says so; never inferred

Securities lawsuit open at the trade date

A securities lawsuit naming the company as a defendant was filed on May 5, 2025 in the U.S. District Court, E.D. Pennsylvania. A filing is an allegation, not a finding.

NEW ENGLAND TEAMSTERS PENSION FUND v. WEST PHARMACEUTICAL SERVICES, INC., docket 2:25-cv-02285, via CourtListener (court records). Nature of suit 850, company named as first defendant